FDA Authorizes Updated Covid Booster Shots

“The Food and Drug Administration on Wednesday authorized the first redesign of coronavirus vaccines since they were rolled out in late 2020, setting up millions of Americans to receive new booster doses targeting Omicron subvariants as soon as next week,” the New York Times reports.

“The agency cleared two options aimed at the BA.5 variant of Omicron that is now dominant: one made by Pfizer and its German partner BioNTech for use in people as young as 12, and the other by Moderna, for those 18 and older.”

Meanwhile, a new New York Times poll finds Americans on the left end of the political spectrum have become less anxious about Covid.